NASDAQ:VACC

Vaccitech - VACC News Today

$2.81

-0.07 (-2.43%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.80
▼
$3.03
50-Day Range: $2.43
▼
$3.15
52-Week Range: $2.02
▼
$7.45

Volume: 22,426 shs
Average Volume: 40,822 shs
Market Capitalization: $104.81 million

P/E Ratio: 8.78
Dividend Yield: N/A
Price Target: $18.00

Institutional Ownership

Get Vaccitech News Delivered to You Automatically

VACC Media Mentions By Week

VACC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VACC
News Sentiment
▼
0.67

0.34
▲
Average
Medical
News Sentiment

VACC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VACC Articles
This Week
▼
5

1
▲
VACC Articles
Average Week

Source

Source	Headline
	Vaccitech (NASDAQ:VACC) Stock Rating Reaffirmed by HC Wainwright americanbankingnews.com - March 21 at 8:30 AM
	Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions finance.yahoo.com - March 20 at 1:06 PM
	Vaccitech Says Prime-boost Vaccine Study Data In Women With Low-grade HPV Lesions Is 'Promising Step In Right Direction' finance.yahoo.com - March 20 at 1:06 PM
	Owning 39% shares,institutional owners seem interested in Vaccitech plc (NASDAQ:VACC), finance.yahoo.com - March 16 at 8:17 AM
	Vaccitech plc (NASDAQ:VACC) Sees Large Decline in Short Interest americanbankingnews.com - March 14 at 5:54 AM
	Prostate Cancer Vaccines Market to Grow Exponentially Due to Rising Demand marketwatch.com - March 13 at 9:53 AM
	Analysts Conflicted on These Healthcare Names: Esperion (ESPR) and Vaccitech Plc (VACC) markets.businessinsider.com - March 6 at 8:59 AM
	Prostate Cancer Vaccines Market : Research Report Analysis by Competitors, Sales, Revenue and Industry Size 2023 To 2028 marketwatch.com - February 2 at 1:38 PM
	Vaccitech appoints new Chief Scientific Officer msn.com - January 30 at 10:14 AM
	Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer finance.yahoo.com - January 30 at 10:14 AM
	The growing tensions around spinouts at British universities ft.com - January 30 at 5:14 AM
	Vaccitech plc (VACC) stock historical prices & data – Yahoo Finance sg.finance.yahoo.com - January 22 at 6:09 PM
	Vaccitech (NASDAQ:VACC) adds US$10m to market cap in the past 7 days, though investors from a year ago are still down 73% finance.yahoo.com - January 13 at 7:49 AM
	H.C. Wainwright Keeps Their Buy Rating on Renalytix AI (RNLX) markets.businessinsider.com - January 10 at 10:13 AM
	Looking Into Vaccitech's Return On Capital Employed benzinga.com - December 22 at 3:17 PM
	Vaccitech to Host KOL Webinar on the SNAPvax™ Platform for Inducing Tolerance to Treat Celiac and other Autoimmune Diseases finance.yahoo.com - November 21 at 10:54 AM
	Vaccitech Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag finance.yahoo.com - November 13 at 9:12 AM
	Vaccitech plc: Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments finanznachrichten.de - November 10 at 7:36 PM
	Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments finance.yahoo.com - November 10 at 7:36 PM
	Vaccitech to Present at Upcoming November Investors Conferences finance.yahoo.com - November 9 at 8:28 AM
	Vaccitech Provides Update on Ongoing VTP-300 Phase 1b/2a Trial Showing Sustained Reductions of HBsAg in Patients with Chronic Hepatitis B finance.yahoo.com - November 7 at 12:57 PM
	Scancell inks licensing deal for technology that will aid development of new cancer treatment proactiveinvestors.com - November 7 at 2:52 AM
	Vaccitech Announces Late-Breaker Abstract Accepted for Presentation at AASLD - The Liver Meeting® Providing Update on the Phase 1b/2a Study of VTP-300 finance.yahoo.com - November 2 at 9:59 AM
	Vaccitech Doses First Patients in HBV003, a Phase 2b Clinical Trial of VTP-300 immunotherapeutic candidate for Chronic HBV Patients finance.yahoo.com - October 31 at 9:32 AM
	Publication in Cell Shows That Vaccitech’s SNAPvax™ Has the Potential to Treat Cancer by Reversing Suppressive Tumor Microenvironment with Novel “Vax-Innate” Paradigm finance.yahoo.com - October 27 at 6:22 PM
	Vaccitech plc (NASDAQ:VACC) stock most popular amongst individual investors who own 33%, while private equity firms hold 31% finance.yahoo.com - October 6 at 3:08 PM
	Vaccitech to Present at Upcoming October Investor & Scientific Conferences finance.yahoo.com - October 3 at 8:45 PM
	Vaccitech Names Gemma Brown as CFO marketwatch.com - September 22 at 12:01 AM
	Vaccitech Promotes Gemma Brown as Chief Financial Officer finance.yahoo.com - September 20 at 5:34 PM
	Vaccitech plc (VACC) ca.finance.yahoo.com - September 16 at 1:07 AM
	Vaccitech PLC Sponsored ADR (VACC) Upgraded to Buy: Here's Why finance.yahoo.com - September 7 at 5:25 PM
	Vaccitech to Present at Upcoming September Investors Conferences finance.yahoo.com - September 7 at 5:25 PM
	Vaccitech well funded through 2024/25 as it progresses its novel immunotherapeutics and vaccines proactiveinvestors.com - August 23 at 9:25 PM
	Vaccitech well funded through 2024/2025 as it progresses its novel immunotherapeutics and vaccines proactiveinvestors.com - August 22 at 10:32 AM
	Growth Investors: Industry Analysts Just Upgraded Their Vaccitech plc (NASDAQ:VACC) Revenue Forecasts By 61% nasdaq.com - August 21 at 8:39 PM
	New Forecasts: Here's What Analysts Think The Future Holds For Vaccitech plc (NASDAQ:VACC) finance.yahoo.com - August 15 at 7:37 AM
	Earnings Beat: Vaccitech plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models nasdaq.com - August 13 at 1:55 PM
	Vaccitech plc Beat Analyst Profit Forecasts, And Analysts Have New Estimates finance.yahoo.com - August 11 at 4:39 PM
	Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments finance.yahoo.com - August 9 at 6:22 PM
	Investors in Vaccitech (NASDAQ:VACC) have unfortunately lost 72% over the last year nasdaq.com - August 3 at 8:02 PM
	Vaccitech to Present at the William Blair Biotech Focus Conference 2022 finance.yahoo.com - July 7 at 4:27 PM
	Investors one-year losses grow to 69% as the stock sheds US$48m this past week finance.yahoo.com - July 3 at 5:59 PM
	Vaccitech's Vaccine Induced Sustained Reductions In Hepatitis B Associated Antigens finance.yahoo.com - June 22 at 8:36 PM
	Vaccitech to raise capital in secondary stock offering seekingalpha.com - June 22 at 3:35 PM
	Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of anti-PD-1 finance.yahoo.com - June 22 at 10:06 AM
	Vaccitech to Present at the Jefferies Healthcare Conference finance.yahoo.com - June 6 at 9:02 PM
	Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus - GlobeNewswire globenewswire.com - June 6 at 10:56 AM
	Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus finance.yahoo.com - June 6 at 10:56 AM
	Vaccitech to Present at the HC Wainwright Global - GlobeNewswire globenewswire.com - May 21 at 1:19 AM
	Vaccitech to Present at the HC Wainwright Global Investment Conference - Benzinga benzinga.com - May 20 at 3:18 PM

Get Vaccitech News Delivered to You Automatically

This page (NASDAQ:VACC) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vaccitech - VACC News Today

VACC Media Mentions By Week

VACC Media Sentiment

VACC News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info